1. Home >
  2. M&A >
  3. Divestiture >
  4. United Kingdom >
  5. Shire Regenerative Medicine Acquires Smith & Nephew - TransCyte Product Line

Divestiture • Life Science

Shire Regenerative Medicine Acquires Smith & Nephew - TransCyte Product Line

On May 31, 2006, Shire Regenerative Medicine acquired life science company Smith & Nephew - TransCyte Product Line from Smith & Nephew

Acquisition Context
  • This is Shire Regenerative Medicine’s 2nd transaction in the Life Science sector.
  • This is Shire Regenerative Medicine’s 2nd transaction in the United Kingdom.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary
Date May 31, 2006
Target Smith & Nephew - TransCyte Product Line
Sector Life Science
Buyer(s) Shire Regenerative Medicine
Sellers(s) Smith & Nephew
Deal Type Divestiture

Target Company

Smith & Nephew - TransCyte Product Line

United Kingdom
Smith & Nephew - TransCyte Product Line is indicated temporary wound covering of burn wound.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Shire Regenerative Medicine

Westport, Connecticut, United States
Category Company
Sector Life Science
DESCRIPTION

Shire Regenerative Medicine, Inc. is a regenerative medicine company that develops, manufactures and commercializes living cell-based therapies for regenerative medicine.

Deal Context for Buyer #
Overall 2 of 2
Sector: Life Science 2 of 2
Type: Divestiture 2 of 2
Country: United Kingdom 2 of 2
Year: 2006 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-05-31 Smith & Nephew - Dermagraft Product

United Kingdom

Smith & Nephew - Dermagraft Product is intended for the treatment of diabetic foot ulcer.

Buy -

Seller Profile 1

SELLER

Smith & Nephew

Watford, United Kingdom
Category Company
Founded 1856
Sector Medical Products
Employees17,000
Revenue 5.8B USD (2024)
DESCRIPTION

Smith & Nephew is a multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, United Kingdom.

Deal Context for Seller #
Overall 2 of 5
Sector: Life Science 2 of 3
Type: Divestiture 2 of 5
Country: United Kingdom 2 of 5
Year: 2006 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-05-31 Smith & Nephew - Dermagraft Product

United Kingdom

Smith & Nephew - Dermagraft Product is intended for the treatment of diabetic foot ulcer.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-07-11 OsteoBiologics

Wermelskirchen, Germany

OsteoBiologics, Inc. located in San Antonio, Texas, develops and manufactures bioabsorbable polymeric scaffolds, films, and related instrumentation for the repair and replacement of bone and articular cartilage. In July 2006, the Company was sold to Smith & Nephew plc for $72.3 million.

Buy $72M

Explore Related M&A Activity

Life Science M&A - Divestiture M&A Deals - United Kingdom M&A - 2006 M&A

Mergr

Solution for

Product

Company

Legal